Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $6,976 - $11,353
-149 Reduced 0.7%
21,184 $1.03 Million
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $49,949 - $78,998
708 Added 3.43%
21,333 $1.51 Million
Q2 2022

Aug 15, 2022

BUY
$50.24 - $80.48 $54,158 - $86,757
1,078 Added 5.51%
20,625 $1.46 Million
Q1 2022

May 13, 2022

BUY
$57.98 - $93.5 $1.13 Million - $1.83 Million
19,547 New
19,547 $1.56 Million
Q3 2020

Nov 12, 2020

SELL
$45.65 - $61.81 $1.07 Million - $1.45 Million
-23,436 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$29.15 - $61.54 $6,004 - $12,677
206 Added 0.89%
23,436 $1.44 Million
Q1 2020

May 06, 2020

BUY
$25.01 - $42.4 $580,982 - $984,952
23,230 New
23,230 $749,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Renaissance Group LLC Portfolio

Follow Renaissance Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.